In the Boston office of GE Ventures, managing director Alex de Winter is overseeing investments in companies like Veracyte, which is applying machine learning to genomic sequencing technology to help doctors distinguish benign growths from cancer. At Intel Capital in the Bay Area, investment director Ranjeet Alexis is an expert in bioinformatics who is scouting […]